PRP Survival Guide

7-PRP Advocacy

PRP Self-Advocacy: Face to Face

It’s a matter of time. For PRP patients and their caregivers, “Face-to-Face’ refers to the number of minutes you spend face-to-face with your dermatologist, e.g., monthly, bi-monthly, quarterly, semi-annually or annually. If your “Face-to-Face Time” per clinic visit is less than 15 minutes, you should find a new dermatologist. “Face-to-Face Time” is not chit chat time — it’s just “MY TURN, […]

PRP Self-Advocacy: Face to Face Read More »

Fiscal Challenges of PRP

Issues related to the financial challenges of PRP PRP patients and caregivers understand the physical challenges of PRP. We all know itch. We all know pain. We know the impact PRP has on vision, mobility, dexterity, and sleep. While the treatment protocols may vary in effectiveness, we can generally call upon healthcare professionals to help

Fiscal Challenges of PRP Read More »

The $20.20 Campaign

Message From Bill McCue, Editor   IMPORTANT: If you have been hurt financially by PRP and/or COVID-19, please do NOT bother reading this message. Just remember the mantra: Stay safe. One day at a time. I have successfully renewed three domains (prpAlliance.com, prpAlliance.org and prpSurvivalGuide.org) that support our PRP global community. We are good for another

The $20.20 Campaign Read More »

PRP Patient Profile Update: June 8, 2020

   Editor’s Note: This webpage provides an overview of the PRP Global Database as of June 8,  2020. ✱   What PRP-related data have we captured? What is still missing? ✱   Why is the data we seek so important to every member of the PRP global community? Whether you are a patient, loving caregiver (spouse, partner, or parent), an extended family

PRP Patient Profile Update: June 8, 2020 Read More »

GARD PRP Report

  The Genetic and Rare Diseases (GARD) Information Center is a program of the National Center for Advancing Translational Sciences. Funded by the National Institutes of Health, GARD supports a variety of programs to serve the needs of patients who have any one of approximately 7,000 rare diseases known today. Their rare disease database includes information

GARD PRP Report Read More »

GARD PRP Report

    Genetic and Rare Diseases (GARD) Inforation Center GARD, a program of the National Center for Advancing Translational Sciences, is funded by the National Institutes of Health. The office supports a variety of programs to serve the needs of patients who have any one of approximately 7,000 rare diseases known today. Their rare disease

GARD PRP Report Read More »